Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;60(5):743-745.
doi: 10.1038/s41409-025-02558-6. Epub 2025 Mar 23.

Impact of daratumumab on the development of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma

Daisuke Minakata  1 , Shin-Ichiro Fujiwara  2 , Seina Honda  1 , Ryutaro Tominaga  1 , Daizo Yokoyama  1 , Atsuto Noguchi  1 , Shuka Furuki  1 , Shunsuke Koyama  1 , Rui Murahashi  1 , Hirotomo Nakashima  1 , Kazuki Hyodo  1 , Shin-Ichiro Kawaguchi  1 , Takashi Ikeda  1 , Yumiko Toda  1 , Kiyomi Mashima  1 , Kento Umino  1 , Masuzu Ueda  1 , Masahiro Ashizawa  1 , Chihiro Yamamoto  1 , Kaoru Hatano  1 , Kazuya Sato  1 , Ken Ohmine  1 , Noriyoshi Fukushima  3 , Yoshinobu Kanda  4   5
Affiliations

Impact of daratumumab on the development of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma

Daisuke Minakata et al. Bone Marrow Transplant. 2025 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: D.M. has received speaking fees from Janssen. M.A. has received speaking fees from Novartis. M.U. has received speaking fees from Janssen, Ono Pharma, Sanofi, Takeda, and BMS. S.-i.F. has received a scholarship from Daiichi Sankyo and honoraria from BMS, CSL Behring, Janssen, Nippon Kayaku, Novartis, Pfizer, Sanofi, and Takeda. K.O. serves as an advisor for Ono and has received speaking fees from Novartis, Takeda, and Ono. Y.K. has received research grants from Sanofi, Ono, Takeda, and Daiichi Sankyo, and payment or honoraria for lectures from BMS, Janssen, Sanofi, Novartis, Pfizer, Ono, Takeda, and Daiichi Sankyo. The other authors have no conflicts of interest to report. Ethics approval and consent to participate: We confirm that all methods were performed in accordance with the relevant guidelines and regulations. This retrospective analysis was approved by the institutional review boards Jichi Medical University Hospital Bioethics Committee for Clinical Research [23-125, 31/Jan/2024]. Regarding the patient consent statement, this study was a retrospective analysis and did not require patient consent. An opt-out procedure was used, and participants were not included in the study if they explicitly decided to exclude. We have not released any personally identifiable images from human research participants in this study.

References

    1. Moreau P, Attal M, Hulin C, Arnulf B, Belhadj K, Benboubker L, et al. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study. Lancet. 2019;394:29–38. https://doi.org/10.1016/S0140-6736(19)31240-1 . - DOI - PubMed
    1. Voorhees PM, Kaufman JL, Laubach J, Sborov DW, Reeves B, Rodriguez C, et al. Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial. Blood. 2020;136:936–45. https://doi.org/10.1182/blood.2020005288 . - DOI - PubMed - PMC
    1. Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, et al. Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. N Engl J Med. 2024;390:301–13. https://doi.org/10.1056/NEJMoa2312054 . - DOI - PubMed
    1. Lee CK, Gingrich RD, Hohl RJ, Ajram KA. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transpl. 1995;16:175–82.
    1. Cornell RF, Hari P, Drobyski WR. Engraftment syndrome after autologous stem cell transplantation: an update unifying the definition and management approach. Biol Blood Marrow Transpl. 2015;21:2061–8. https://doi.org/10.1016/j.bbmt.2015.08.030 . - DOI

LinkOut - more resources